share_log

Mateon Therapeutics Inc | 424B3: Prospectus

SEC ·  Jun 3, 2021 13:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more